Brigatinib in patients with ALK‐positive anaplastic large cell lymphoma who have failed brentuximab vedotin

Bibliographic Details
Title: Brigatinib in patients with ALK‐positive anaplastic large cell lymphoma who have failed brentuximab vedotin
Authors: Veleanu, L., Tesson, B., Lamant, L., Marçais, A., Bruneau, J., Kaltenbach, S., Brouzes, C., Degoutte, C., Moraly, J., Villarese, P., Lhermitte, L., Latiri, M., Hure, G., Chauchet, A., Delette, C., Grosleron, S., Toussaint, E., Cabrera, Q., Brice, P., Gros, F., Clavert, A., Oberic, L., Le Goff, M., Cereja, S., Meggetto, F., Macintyre, E., Asnafi, V., Sibon, D.
Source: Hematological oncology. 41:505-506
Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100185005803.0x000001&indx=1&recIds=ETOCvdc_100185005803.0x000001
Database: British Library Document Supply Centre Inside Serials & Conference Proceedings
More Details
ISSN:02780232
Published in:Hematological oncology
Language:English